×
-0.000285632676378121 -0.000285632676378121 -0.000285632676378121 -0.0111396743787489 0.0339902884890033 -0.0117109397315052 -0.00314195944015994 0.00114253070551289
Stockreport

Momenta Pharma sees market launch of Glatopa 40 mg by mid-year; shares ahead 8% premarket [Seeking Alpha]

MOMENTA PHARMACEUTICALS (MNTA)  More Company Research Source: Seeking Alpha
Last momenta pharmaceuticals earnings: 2/21 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.momentapharma.com/investor-relations
PDF Momenta Pharma sees market launch of Glatopa 40 mg by mid-year; shares ahead 8% premarketMomenta Pharmaceuticals (NASDAQ:MNTA) is up8% premarket on light volume on the heels of itsannouncement that the FDA has classified its Q4 2017 reinspection of Pfizer's McPhearson manufacturing site as "Voluntary Action Indicated" which means that some minor deficiencies were observed but the issues do not warrant further regulatory action.The McPhearson site will manufacture Momenta's generic 40 mg version of Teva Pharmaceutical Industries' (NYSE:TEVA) top seller Copaxone (glatiramer acetate injection). The FDA would not approve its ANDA until the issues at the plant were resolved. Momenta now believes it will receive U.S. approval by next quarter. It will market its offering under the brand name Glatopa.Teva is down6% premarket on robust volume.Previously:FDA OK of Momenta's 40mg Glatopa delayed due to compliance issues at manufacturing site; shares down 15% (Feb. 21, 2017)See all stocks on the [Read more]

IMPACT SNAPSHOT EVENT TIME: MNTA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS